| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4260a256b5f28ea7d92b4c1f5b921d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8439620a398eef37ea05d64c59b6c3db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1123c977ae04855b38c495d5bef6b922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e872f608981301699fb05f1128872ba3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2005-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06ffaeecd07a9441663f1f688e398f8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d031010f71e83b9f97d320498d14236c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d21dd1321824cb07a6f08305b59c48 |
| publicationDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8318179-B2 |
| titleOfInvention |
Neisserial vaccines |
| abstract |
The present invention relates to compositions comprising at least one purified PorA protein antigen and at least one purified FetA protein antigen. In particular, said PorA/FetA antigens are antigenically variable antigens comprising the variable regions of PorA/FetA. Specific combinations of PorA/FetA epitopes are presented for example in Table 3. The invention also relates to methods of immunization comprising administering said compositions, and to methods for producing compositions. Preferably the compositions are purified protein compositions. Preferably the compositions are vaccine compositions. |
| priorityDate |
2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |